Claris Lifesciences has informed that the Board of Directors of the Company at the meeting held on December 15, 2016 (commenced at 5:00 PM and concluded at 6:30 PM) has approved the sale and transfer of the Injectable Business of Claris Lifesciences Limited (CLL or the Company) by way of sale of the subsidiary companies Claris Injectables Limited, Claris Pharmaservices, Elda International DMCC, Claris Lifesciences Inc., Claris Lifesciences (UK) Limited, Claris Lifesciences (Aust) Pty. Limited, Claris Lifesciences Philippines, INC.
The above information is a part of company’s filings submitted to BSE.
